Quick Answer
LifeStance Health Group, Inc. reported Total Revenue of $1.42 billion for fiscal year 2025.
LifeStance Health Group, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.42B +13.9% |
$1.25B +18.5% |
$1.06B +22.8% |
$859.54M +28.8% |
$667.51M | — |
| Net Income | $9.66M +116.8% |
-$57.44M +69.2% |
-$186.26M +13.6% |
-$215.56M +29.8% |
-$307.20M | — |
| Total Assets | $2.20B +4.0% |
$2.12B +0.4% |
$2.11B -2.9% |
$2.17B +12.8% |
$1.93B +22.8% |
$1.57B |
| Cash and Equivalents | $248.64M +60.9% |
$154.57M +96.1% |
$78.82M -27.4% |
$108.62M -26.6% |
$148.03M +686.2% |
$18.83M |
| Long-Term Debt | $265.93M -5.0% |
$279.79M -0.2% |
$280.29M +24.5% |
$225.08M +43.0% |
$157.42M -56.6% |
$362.53M |
| Stockholders Equity | $1.52B +5.2% |
$1.45B +1.2% |
$1.43B -5.9% |
$1.52B -1.7% |
$1.55B | $0.00 +100.0% |
| Operating Income | $24.15M +176.4% |
-$31.61M +83.3% |
-$189.13M +10.0% |
-$210.17M +26.6% |
-$286.35M | — |
| Shares Outstanding | 388.32M +1.5% |
382.74M +1.1% |
378.73M +0.7% |
375.96M +0.5% |
374.25M | 0 |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $363.81M | +16.3% | +5.4% |
| Net Income | September 30, 2025 | $1.08M | +118.1% | +128.4% |
| Total Assets | September 30, 2025 | $2.15B | +1.9% | +0.1% |
| Cash and Equivalents | September 30, 2025 | $203.90M | +98.7% | +7.9% |
| Long-Term Debt | September 30, 2025 | $269.39M | -3.5% | -1.3% |
| Stockholders Equity | September 30, 2025 | $1.49B | +3.9% | +1.3% |
| Operating Income | September 30, 2025 | $7.41M | +15666.0% | +351.2% |
| Shares Outstanding | September 30, 2025 | 389.00M | +1.7% | -0.0% |
- LifeStance Health Group, Inc. reported Total Revenue of $1.42 billion for fiscal year 2025.
- LifeStance Health Group, Inc. showed an increase of +13.9% in Total Revenue compared to the prior fiscal year.
- LifeStance Health Group, Inc. reported Net Income of $9.66 million for fiscal year 2025.
- LifeStance Health Group, Inc. showed an increase of +116.8% in Net Income compared to the prior fiscal year.
- LifeStance Health Group, Inc. reported Total Assets of $2.20 billion for fiscal year 2025.
- LifeStance Health Group, Inc. showed an increase of +4.0% in Total Assets compared to the prior fiscal year.
- LifeStance Health Group, Inc. reported Cash and Equivalents of $248.64 million for fiscal year 2025.
- LifeStance Health Group, Inc. showed an increase of +60.9% in Cash and Equivalents compared to the prior fiscal year.
- LifeStance Health Group, Inc. reported Long-Term Debt of $265.93 million for fiscal year 2025.
- LifeStance Health Group, Inc. showed a decrease of -5.0% in Long-Term Debt compared to the prior fiscal year.
- LifeStance Health Group, Inc. reported Stockholders Equity of $1.52 billion for fiscal year 2025.
- LifeStance Health Group, Inc. showed an increase of +5.2% in Stockholders Equity compared to the prior fiscal year.
- LifeStance Health Group, Inc. reported Operating Income of $24.15 million for fiscal year 2025.
- LifeStance Health Group, Inc. showed an increase of +176.4% in Operating Income compared to the prior fiscal year.
- LifeStance Health Group, Inc. reported Shares Outstanding of 388.32 million shares for fiscal year 2025.
- LifeStance Health Group, Inc. showed an increase of +1.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: